Mechanisms and Drug-Augmenting Strategies of Mesenchymal Stem Cells for Preserving β-Cell in Type 2 Diabetes
Authors:
- Kunlu WangKWKunlu Wang
- Jiuwei LiJLJiuwei Li
- Cong HanCHCong Han
- Jie LiJLJie Li
Open Access
- 1 April 2026
- journal article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-26
Abstract
Type 2 diabetes (T2D) is closely linked to β-cell dysfunction. Preserving β-cell function has emerged as a critical therapeutic strategy for T2D. Mesenchymal stem cells (MSCs) have demonstrated remarkable potential in achieving this goal. This paper systematically reviews the multifaceted mechanisms by which MSCs protect pancreatic β-cell function in T2D. It integrates eight core mechanisms: modulating the inflammatory microenvironment, regulating the immune system, counteracting oxidative stress, enhancing autophagy levels, alleviating endoplasmic reticulum stress, safeguarding mitochondrial function, promoting β-cell regeneration and repair, and inhibiting ferroptosis. Together, these form a multi-layered, networked intervention system. This framework elucidates MSC protective effects across three functional levels: eliminating injury initiators, maintaining cellular homeostasis, and intervening in cellular fate outcomes. Additionally, this review examines pharmacological strategies to enhance MSC efficacy, including hypoglycemic agents, other drugs, and natural products, with a focus on their mechanisms of action and barriers to clinical translation. Finally, based on MSC advantages and existing research limitations, we propose future research directions, including optimizing MSC source selection and engineering MSC-derived exosomes. These recommendations aim to provide theoretical foundations and strategic references for MSC-based T2D therapies.Keywords
This publication has 156 references indexed in Scilit:
- Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transferStem Cells, 2020
- Immunomodulatory effects of mesenchymal stem cell–derived exosomes on experimental type‐1 autoimmune diabetesJournal of Cellular Biochemistry, 2018
- Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic ratsStem Cells, 2015
- TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6Diabetologia, 2014
- Bone marrow mesenchymal stem cells ameliorate inflammatory factor-induced dysfunction of INS-1 cells on chipCell Biology International, 2014
- Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetesDiabetologia, 2014
- Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacyThe EMBO Journal, 2014
- Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in miceDiabetologia, 2011
- Islet-associated macrophages in type 2 diabetesDiabetologia, 2009
- Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cellsDiabetologia, 2009